Tell your friends about this item:
Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development N Ferrari
Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development
N Ferrari
Antisense-based drugs are part of a growing number of pharmaceutical and biotech programs to treat diseases including cancer, diabetes, and ALS. Reviewing fundamentals and offering guidelines for drug discovery and development, this book is a practical guide from the safety assessment to clinical experience with antisense oligonucleotides.
576 pages
| Media | Books Hardcover Book (Book with hard spine and cover) |
| Released | July 31, 2018 |
| ISBN13 | 9781118537336 |
| Publishers | John Wiley & Sons Inc |
| Pages | 576 |
| Dimensions | 160 × 231 × 33 mm · 898 g |
| Language | English |
| Editor | Ferrari, Nicolay |
| Editor | Seguin, Rosanne |